Wird geladen...
Ruxolitinib: a targeted treatment option for patients with polycythemia vera
Polycythemia vera (PV) is a chronic myeloproliferative neoplasm characterized by erythrocytosis and the presence of Janus kinase (JAK) 2V617F or similar mutations. This review summarizes the pathophysiology of PV, the challenges associated with traditional treatment options, and the scientific ratio...
Gespeichert in:
| Veröffentlicht in: | Blood Lymphat Cancer |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6467337/ https://ncbi.nlm.nih.gov/pubmed/31360077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S101185 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|